NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch » TOP 50 Pharmas » Schering-Plough  1    
found files: 5
Schering-Plough »22/05/2008 [Company watch]
Shanghai Schering-Plough buys out JV Partner

Shanghai Schering-Plough is poised to follow Baxter Healthcare (Shanghai) and other multinationals in buying out local joint venture partners. This week, two domestic enterprises put their combined 45% stake of Shanghai Schering-Plough Pharmaceutical up for sale for RMB 66,329,550. Schering-Plough China, which owns 55%, is interested in purchasing the stake to achieve 100% ownership. In an interview a Schering-Plough spokesperson commented that the transaction is "going well", and if no other parties bid for the stake, the deal is expected to close by the end of June....   more»

Schering-Plough »30/06/2008 [Company watch]
Schering-Plough China buys back Shanghai Schering

According to the Shanghai United Assets and Equity Exchange, 45% equity of Shanghai Schering-Plough Ltd. held by Shanghai Pharmaceutical Group and Shanghai Pharmaceutical Industry Corporation has been sold to Schering-Plough China for RMB 66.3 million, a move that will make Shanghai Schering-Plough a wholly foreign-owned enterprise once the transaction is finalized in July. Shanghai Schering-Plough Pharmaceutical, a joint venture, has a registered capital of USD 21 million. Prior to the sale, 30% of the firm was held by Shanghai Pharmaceutical Industry Corporation, 15% by Shanghai Pharmaceutical (Group), and the remaining 55% by Schering-Plough China. There remains some controversy surrounding the share sale; local media claim the New-Jersey based MNC has pursued a 'loss strategy' to drive out its Chinese partners. A spokesperson from Shanghai Pharmaceutical (Group), however, denied the claims, stating that the share sale is due to the Group's unwillingness to guarantee new loans to the company....   more»

Schering-Plough »14/08/2008 [Company watch]
Schering-Plough Takes Sole Possession of Its China JV

Schering-Plough Corporation bought the 45% of its majority-owned China JV, Shanghai Schering-Plough Pharmaceutical, that it did not already own. Its former partners, Shanghai Pharmaceutical Group and Shanghai Pharmaceutical Industry Corporation, put the 45% stake up for sale in May, saying they wanted to streamline their business into fewer subsidiaries. At the time, the two companies were asking 66.3 million RMB ($9.6 million) for their stake. Schering-Plough did not disclose the final price. Schering-Plough representatives portrayed the acquisition as an expansion of the company‚Äôs involvement in China. Established in 1994, the JV manufactures, markets and distributes allergy and skincare products. In China, Schering-Plough is active in the therapeutic areas of allergy/respiratory, cardiovascular, central nervous system, skin care, oncology, infectious diseases, and women's health. The JV, which employs more than 1,000 people in China, posted a net profit of $500,000 in 2007 after two years of losses. It was formed two years after Schering-Plough opened its first offices in China cities, though the company has been selling pharmaceuticals in the China market since the 1980s....   more»

Schering-Plough »15/12/2008 [Company watch]
Huya Bioscience today announced an agreement with Schering-Plough

HUYA Bioscience International, a leader in US/China pharmaceutical co-development, today announced an agreement with Schering-Plough Corporation\'s subsidiary, N.V. Organon....   more»

Schering-Plough »15/12/2008 [Company watch]
HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China

Collaboration will leverage HUYA\'s growing Chinese bioscience network...   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.